Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Nov 15, 2021; 13(11): 1709-1724
Published online Nov 15, 2021. doi: 10.4251/wjgo.v13.i11.1709
Published online Nov 15, 2021. doi: 10.4251/wjgo.v13.i11.1709
Figure 2 Higher CBX8 expression induces worse clinical outcome in pancreatic cancer tissue.
A: The mRNA expression of CBX8 in 116 paired pancreatic cancer (PC) and normal tissues measured by quantitative reverse transcription-PCR; B: Kaplan–Meier survival of patients with high and low CBX8 mRNA level; C: Protein expression of CBX8 in 20 paired PC and normal tissues measured by Western blot; D: Heatmap indicating genes positively related with CBX8; E: KEGG pathway analysis of genes in positive relation with CBX8. bP < 0.01.
- Citation: Teng BW, Zhang KD, Yang YH, Guo ZY, Chen WW, Qiu ZJ. Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis. World J Gastrointest Oncol 2021; 13(11): 1709-1724
- URL: https://www.wjgnet.com/1948-5204/full/v13/i11/1709.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i11.1709